Neovacs
ALNEV | Euronext Growth
Overview
Corporate Details
- ISIN(s):
- FR0004032746 (+4 more)
- LEI:
- 9695001J9GMM5XYK6482
- Country:
- France
- Address:
- 14 RUE DE LA REPUBLIQUE, 92150 SURESNES
- Website:
- https://www.neovacs.com/en/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Founded in 1993 as a spin-off of Paris Sorbonne (formerly Pierre and Marie Curie University), our ambition is to develop our Kinoid products, resulting from patented technologies, and to invest in innovative companies such as Biotech and Medtech. At research and development, our activities revolve around the Kinoid technological platform in two main therapeutic indications, lupus disease and allergies. This innovative approach allows the patient's immune system to regulate the harmful overproduction of cytokines (active immunotherapy). Neovacs'Kinoid technology, used in particular in the treatment of lupus disease, is patented until 2040. Our investment activity leverages the skills of our experienced scientific and financial teams to invest in promising projects, both in the development of drug candidates (BioTech) and medical devices (MedTech).
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-16 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 230.1 KB | |
| 2025-05-06 20:00 |
Share Issue/Capital Change
Ajustement de la valeur nominale
|
French | 213.4 KB | |
| 2025-05-06 08:00 |
Earnings Release
Résultats annuels 2024
|
French | 255.3 KB | |
| 2025-05-05 12:00 |
Capital/Financing Update
Levée de fonds de 1,2 MEUR
|
French | 231.2 KB | |
| 2025-04-30 18:00 |
Capital/Financing Update
Levée de fonds de 0,25 MEUR
|
French | 234.1 KB | |
| 2025-04-17 18:30 |
Capital/Financing Update
Levée de fonds de 0,25 M EUR
|
French | 248.3 KB | |
| 2025-04-16 08:00 |
Regulatory News Service
Néovacs fait le point sur des rumeurs
|
French | 235.6 KB | |
| 2025-04-02 20:00 |
Share Issue/Capital Change
Ajustement de la valeur nominale
|
French | 210.1 KB | |
| 2025-03-28 08:00 |
Regulatory News Service
Néovacs co-organise la 1ère rencontre Française sur les Nanoparticules Lipidiqu…
|
French | 225.9 KB | |
| 2025-03-25 08:00 |
Capital/Financing Update
Signature d'un avenant à la convention de fiducie
|
French | 238.6 KB | |
| 2025-03-17 20:00 |
Capital/Financing Update
Levée de fonds de 0,25 MEUR
|
French | 231.5 KB | |
| 2025-03-14 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Information relative au nombre total de droits de vote et d'actions composant l…
|
French | 226.8 KB | |
| 2025-03-06 08:00 |
Regulatory News Service
Sur la base d'une valorisation indépendante de son actif le plus avancé à plus …
|
French | 235.0 KB | |
| 2025-03-04 08:00 |
Regulatory News Service
Néovacs a présenté les derniers résultats de son candidat-vaccin à ARN messager…
|
French | 243.2 KB | |
| 2025-01-21 21:00 |
Capital/Financing Update
Levée de fonds de 0,25 MEUR
|
French | 231.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |